Ståhle L - Search Results

1

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.

Wang J, Sönnerborg A, Rane A, Josephson F, Lundgren S, Ståhle L, Ingelman-Sundberg M. Wang J, et al. Among authors: stahle l. Pharmacogenet Genomics. 2006 Mar;16(3):191-8. doi: 10.1097/01.fpc.0000189797.03845.90. Pharmacogenet Genomics. 2006. PMID: 16495778

2

Efavirenz plasma concentrations in HIV-infected patients: inter- and intraindividual variability and clinical effects.

Ståhle L, Moberg L, Svensson JO, Sönnerborg A. Ståhle L, et al. Ther Drug Monit. 2004 Jun;26(3):267-70. doi: 10.1097/00007691-200406000-00008. Ther Drug Monit. 2004. PMID: 15167626 Clinical Trial.

3

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.

Xie H, Griskevicius L, Ståhle L, Hassan Z, Yasar U, Rane A, Broberg U, Kimby E, Hassan M. Xie H, et al. Among authors: stahle l. Eur J Pharm Sci. 2006 Jan;27(1):54-61. doi: 10.1016/j.ejps.2005.08.008. Epub 2005 Sep 23. Eur J Pharm Sci. 2006. PMID: 16183265 Clinical Trial.

4

Efficacy of nelfinavir-based treatment in the central nervous system of HIV-1 infected patients.

Karlström O, Ståhle L, Perrin L, Tegude H, Sönnerborg A. Karlström O, et al. Among authors: stahle l. Scand J Infect Dis. 2006;38(5):371-4. doi: 10.1080/00365540500469535. Scand J Infect Dis. 2006. PMID: 16709540

5

Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system.

Martin C, Sönnerborg A, Svensson JO, Ståhle L. Martin C, et al. Among authors: stahle l. AIDS. 1999 Jul 9;13(10):1227-32. doi: 10.1097/00002030-199907090-00012. AIDS. 1999. PMID: 10416527 Clinical Trial.

6

Rapid and simple determination of indinavir in serum, urine, and cerebrospinal fluid using high-performance liquid chromatography.

Svensson JO, Sönnerborg A, Ståhle L. Svensson JO, et al. Among authors: stahle l. Ther Drug Monit. 2000 Oct;22(5):626-9. doi: 10.1097/00007691-200010000-00020. Ther Drug Monit. 2000. PMID: 11034271

7

Switching antiretroviral therapy from an enzyme-inducing drug.

Gyllensten K, Sönnerborg A, Ståhle L. Gyllensten K, et al. Among authors: stahle l. Ther Drug Monit. 2000 Oct;22(5):637-8. doi: 10.1097/00007691-200010000-00023. Ther Drug Monit. 2000. PMID: 11034274 No abstract available.

8

Antiretroviral treatment of human immunodeficiency virus infection: Swedish recommendations.

Sandström E, Uhnoo I, Ahlqvist-Rastad J, Bratt G, Berglund T, Gisslén M, Lindbäck S, Morfeldt L, Ståhle L, Sönnerborg A; Swedish Consensus Group. Sandström E, et al. Among authors: stahle l. Scand J Infect Dis. 2003;35(3):155-67. doi: 10.1080/00365540310006395. Scand J Infect Dis. 2003. PMID: 12751710 Review.

9

Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids.

Gårevik N, Strahm E, Garle M, Lundmark J, Ståhle L, Ekström L, Rane A. Gårevik N, et al. Among authors: stahle l. J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):295-300. doi: 10.1016/j.jsbmb.2011.08.005. Epub 2011 Aug 22. J Steroid Biochem Mol Biol. 2011. PMID: 21884791

10

Indinavir in cerebrospinal fluid of HIV-1-infected patients.

Ståhle L, Martin C, Svensson JO, Sönnerborg A. Ståhle L, et al. Lancet. 1997 Dec 20-27;350(9094):1823. doi: 10.1016/S0140-6736(05)63640-9. Lancet. 1997. PMID: 9428261 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters